A meta-analysis of chemotherapy regimen Fluorouracil/Leucovorin/Oxaliplatin Compared with Fluorouracil/Leucovorin in treating advanced colorectal cancer

Surgical Oncology

Volumn 19, Issue 1, 2010, Pages 38-45

  Chen, Mian Ling ^a   Fang, Chi Hua ^b   Liang, Liu Sen ^a   Dai, Li Hua ^a   Wang, Xiao Kang ^a  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

5 Fluorouracil; Chemotherapy; Colorectal cancer; Leucovorin; Meta analysis; Oxaliplatin

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; PLATINUM COMPLEX; VITAMIN B COMPLEX;

ANEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DRUG EFFICACY; ECHOGRAPHY; HUMAN; NAUSEA; NEUROTOXICITY; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; THROMBOCYTOPENIA; VOMITING; ADULT; AGED; CHEMICALLY INDUCED; CHINA; COLORECTAL NEOPLASMS; CONFIDENCE INTERVAL; DISEASE COURSE; FEMALE; INCIDENCE; MALE; META ANALYSIS; MIDDLE AGED; MORTALITY; RISK; SENSITIVITY AND SPECIFICITY; SURVIVAL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHINA; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HUMANS; INCIDENCE; LEUCOVORIN; MALE; MIDDLE AGED; NEUTROPENIA; ODDS RATIO; ORGANOPLATINUM COMPOUNDS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; VITAMIN B COMPLEX; YOUNG ADULT;

EID: 76049104272     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2009.02.015     Document Type: Review

References (11)

1. Goldberg R.M., Sargent D.J., Morton R.F., Fuchs C.S., Ramanathan R.K., Williamson S.K., et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal caner. Journal of Clinical Oncology 22 1 (2004) 23-30
2. Figer A., Perez-Staub N., Carola E., Tourniqand C., Lledo G., Flesch M., et al. FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study. Cancer 110 12 (2007) 2666-2671
3. de Gramont A., Figer A., Seymour M., Homerin M., Hmissi A., Cassidy J., et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. Journal of Clinical Oncology 18 16 (2000) 2938-2947
4. Wasserberg N., and Kaufman H.S. Palliation of colorectal cancer. Surgical Oncology 16 (2007) 299-310
5. Tashiro T., Kawada Y., Sakurai Y., and Kidani Y. Antitumor activity of a new platinum complex, oxalato(trans-1-1, 2-diaminocyclohexane) platinum (II): new experimental data. Biomedicine & Phamacotherapy 43 (1989) 251-260
6. Raymond E., Buquet-Fagot C., Djelloul S., Mester J., Cvitkovic C., Allain P., et al. Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast, and ovarian cancers. Anticancer Drugs 8 (1997) 876-885
7. Ibrahim A., Hirschfeld S., Cohen M.H., Griebel D.J., Williams G.A., and Pazdur R. FDA drup approval summaries: oxaliplatin. The Oncologist 9 (2004) 8-12
8. Hospers G.A.P., Schaapveld M., Nortier J.W., Wils J., van Bochove A., de Jong R.S., et al. Randomised phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer. Annals of Oncology 17 (2006) 443-449
9. Kemeny N., Garay C.A., Gurtler J., Hochster H., Kennedy P., Benson A., et al. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer. Journal of Clinical Oncology 22 23 (2004) 4753-4761
10. Rothernberg M.L., Oza A.M., Bigelow R.H., Berlin J.D., Marshall J.L., Ramanathan R.K., et al. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. Journal of Clinical Oncology 21 11 (2003) 2059-2069
11. Giacchetti S., Perpoint B., Zidani R., Le Bail N., Faqqiuolo R., Focan C., et al. Phases III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. Journal of Clinical Oncology 18 (2000) 136-147